DK143749B - PROCEDURE FOR THE PREPARATION OF 4- (HYDROXYMETHYL) IMIDAZOLE COMPOUNDS SOA AND ITS ACID ADDITION SALTS - Google Patents

PROCEDURE FOR THE PREPARATION OF 4- (HYDROXYMETHYL) IMIDAZOLE COMPOUNDS SOA AND ITS ACID ADDITION SALTS Download PDF

Info

Publication number
DK143749B
DK143749B DK331976AA DK331976A DK143749B DK 143749 B DK143749 B DK 143749B DK 331976A A DK331976A A DK 331976AA DK 331976 A DK331976 A DK 331976A DK 143749 B DK143749 B DK 143749B
Authority
DK
Denmark
Prior art keywords
added
ammonia
hydroxymethyl
imidazole
ester
Prior art date
Application number
DK331976AA
Other languages
Danish (da)
Other versions
DK331976A (en
DK143749C (en
Inventor
E L Anderson
W L Mendelson
G R Wellman
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/690,476 external-priority patent/US4063023A/en
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of DK331976A publication Critical patent/DK331976A/en
Publication of DK143749B publication Critical patent/DK143749B/en
Application granted granted Critical
Publication of DK143749C publication Critical patent/DK143749C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Description

(19) DANMARK(19) DENMARK

^ (ni FREMLÆGGELSESSKRIFT od 143749 B^ (ni PUBLICATION MANUAL od 143749 B

DIREKTORATET FOR PATENT- OG VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT AND TRADEMARKET SYSTEM

(21) Ansøgning nr. 3519/76 (§1) IntCI* C 07 D 233/64 (22) Indleveringsdag 22. Jul. 1976 (24) Løbedag 22. Jul. 1976 (41) Aim. tilgængelig 21. feb. 1977 (44) Fremlagt 5· okt. 1981 (86) International ansøgning nr. -(86) International indleveringsdag -(85) Videreførelsesdag -(62) Stamansøgning nr. -(21) Application No. 3519/76 (§1) IntCI * C 07 D 233/64 (22) Filing date 22 Jul. 1976 (24) Race day 22 Jul. 1976 (41) Aim. available Feb 21 1977 (44) Posted 5 Oct. 1981 (86) International Application No. - (86) International Filing Day - (85) Continuation Day - (62) Master Application No. -

(30) Prioritet 20. aug. 1975, 606270, US 27· maj 1976, 690476, US(30) Priority 20 Aug. 1975, 606270, US May 27, 1976, 690476, US

(71) Ansøger SMITHKLINE CORPORATION, Philadelphia, US.(71) Applicant SMITHKLINE CORPORATION, Philadelphia, US.

(72) Opfinder Elvin Lowell Anderson, US: Wilford Lee Mendelson, US: George Robert Wellman, US.(72) Inventor Elvin Lowell Anderson, US: Wilford Lee Mendelson, US: George Robert Wellman, US.

(74) Fuldmægtig Firmaet Chas. Hude.(74) Associate Company Chas. Hude.

(54) Fremgangsmåde til fremstilling af 4-(hydroxymethyl)imidazolforbin« delser såvel som syreadditions« salte deraf.(54) Process for the preparation of 4- (hydroxymethyl) imidazole compounds as well as their acid addition salts.

Opfindelsen angår en forbedret fremgangsmåde til fremstilling af 4-(hydroxymethyl)imidazolforbindelser med formlenThe invention relates to an improved process for the preparation of 4- (hydroxymethyl) imidazole compounds of the formula

Ry_ζ CE^OHRy_ζ CE ^ OH

HN^KHN ^ K

IQ hvori R er hydrogen eller C1_4-alkyl/eller syreadditionssalte deraf, j) ved hvilken en 4-imidazolcarboxylsyrealkylester med formlenWherein Q is hydrogen or C 1-4 alkyl and / or acid addition salts thereof, j) wherein a 4-imidazole carboxylic acid alkyl ester of formula

o 7^To 7 ^ T

=t HN^N= t HN ^ N

r— hvori R er som ovenfor defineret, og R' er lavere alkyl, reduceres, hvilken fremgangsmåde er ejendommelig ved, at reduktionen foretagesr - wherein R is as defined above and R 'is lower alkyl, which method is characterized by the reduction being made

DD

2 143749 med et alkalimetal eller calcium i flydende ammoniak samt i nærværelse af en yderligere protonafgivende forbindelse, der tilføres under omsætningen eller under oparbejdningen, hvorefter 4-(hydroxymethyl)-imidazolen om ønsket isoleres som et syreadditionssalt.No. 2,23749 with an alkali metal or calcium in liquid ammonia and in the presence of an additional proton-releasing compound which is added during the reaction or during work-up, and if desired, the 4- (hydroxymethyl) imidazole is isolated as an acid addition salt.

4-(hydroxymethyl)imidazolforbindelser kan fremstilles ved reduktion af 4-imidazolcarboxylsyreestere under anvendelse af lithiumaluminium-hydrid. Denne fremgangsmåde er kostbar, især til fremstilling af 4-(hydroxymethyl)imidazoler i stor skala.4- (hydroxymethyl) imidazole compounds can be prepared by reduction of 4-imidazole carboxylic acid esters using lithium aluminum hydride. This process is expensive, especially for the preparation of 4- (hydroxymethyl) imidazoles on a large scale.

Tamamushi, J. Pharm. Soc. Japan 53: 664-8 (1933), C.A. 28:20049 (1934), har omtalt, at forsøg på reduktion af 2-methylimidazol-4,5-dicarboxyl-syre og estere deraf ved hjælp af forskellige metoder ikke var vellykkede. Med 5-monochloridet resulterer reduktion med Sn og HC1 i dannelsen af 2-methyl-5-hydroxymethylimidazol-4-carboxylsyre.Tamamushi, J. Pharm. Soc. Japan 53: 664-8 (1933), C.A. 28: 20049 (1934), have reported that attempts to reduce 2-methylimidazole-4,5-dicarboxylic acid and their esters by various methods were unsuccessful. With the 5-monochloride, reduction with Sn and HCl results in the formation of 2-methyl-5-hydroxymethylimidazole-4-carboxylic acid.

Det er kendt, at heterocykliske ringsystemer kan reduceres ved hjælp af metaller i flydende ammoniak via en reaktion af Birch-typen. For eksempel omtaler Remers et al., J. Amer. Chem. Soc. 89:5513-4 (1967), at indol og quinolinringe reduceres ved anvendelse af lithium og methanol i flydende ammoniak. Endvidere omtaler O'Brien et al., J. Chem. Soc. 4609-4612, (1960), at indol- og carbazolringe, men ikke pyrrolringe, kan reduceres ved hjælp af metaller i flydende ammoniak i nærværelse af alkohol. Ved fremgangsmåden ifølge opfindelsen reduceres carboxylsyreestergruppen i en 4-imidazolcarboxylsyreester selektivt til hydroxymethyl uden reduktion af imidazolringen ved anvendelse af et alkalimetal eller calcium i flydende ammoniak samt en yderligere protonafgivende forbindelse.It is known that heterocyclic ring systems can be reduced by metals in liquid ammonia via a Birch-type reaction. For example, Remers et al., J. Amer. Chem. Soc. 89: 5513-4 (1967) that indole and quinoline rings are reduced by using lithium and methanol in liquid ammonia. Further, O'Brien et al., J. Chem. Soc. 4609-4612, (1960), that indole and carbazole rings, but not pyrrole rings, can be reduced by using liquid ammonia metals in the presence of alcohol. In the process of the invention, the carboxylic acid ester group in a 4-imidazole carboxylic acid ester is selectively reduced to hydroxymethyl without reduction of the imidazole ring using an alkali metal or calcium in liquid ammonia as well as an additional proton-releasing compound.

Fremgangsmåden ifølge den foreliggende opfindelse er fordelagtig, især i forbindelse med de foretrukne alkalimetaller, dvs. natrium, kalium og lithium, fordi de til reduktionen af imidazolcarboxylsyre-estrene benyttede materialer ikke er dyre, og fordi der opnås høje udbytter af hydroxymethylimidazolerne i en høj renhedsgrad, dvs. mindst 90% renhed.The process of the present invention is advantageous, especially in connection with the preferred alkali metals, i.e. sodium, potassium and lithium because the materials used for the reduction of the imidazole carboxylic acid esters are not expensive and because high yields of the hydroxymethylimidazoles are obtained in a high degree of purity, ie. at least 90% purity.

Fremgangsmåden ifølge opfindelsen kan illustreres som følger: 3 U37A9The process of the invention can be illustrated as follows: 3 U37A9

Rv_/COOR' R χ y CH2°HRv_ / COOR 'R χ y CH2 ° H

t=\ r=\t = \ r = \

HN N -^ HN NHN N - ^ HN N

Formel I Formel IIFormula I Formula II

hvori R er hydrogen eller alkyl med 1 til 4 carbonatomer, fortrinsvis methyl, og R' er lavere alkyl med 1 til 4 carbonatomer, fortrinsvis methyl eller ethyl.wherein R is hydrogen or alkyl of 1 to 4 carbon atoms, preferably methyl, and R 'is lower alkyl of 1 to 4 carbon atoms, preferably methyl or ethyl.

Ifølge den ovennævnte fremgangsmåde reduceres en lavere alkylester af en 4-imidazolcarboxylsyre under anvendelse af et alkalimetal eller calcium i flydende ammoniak med en yderligere protonafgivende forbindelse til opnåelse af en 4-(hydroxymethyl)imidazol. Fortrinsvis anvendes et alkalimetal, idet natrium eller lithium er mest foretrukket. Fire ækvivalenter af alkalimetallet eller to ækvivalenter calcium kræves for hvert ækvivalent af esteren. Fortrinsvis er lidt mere end 4 ækvivalenter af alkalimetallet eller lidt mere end 2 ækvivalenter calcium til stede.According to the above process, a lower alkyl ester of a 4-imidazole carboxylic acid is reduced using an alkali metal or calcium in liquid ammonia with an additional proton-releasing compound to give a 4- (hydroxymethyl) imidazole. Preferably, an alkali metal is used, with sodium or lithium being most preferred. Four equivalents of the alkali metal or two equivalents of calcium are required for each equivalent of the ester. Preferably, slightly more than 4 equivalents of the alkali metal or slightly more than 2 equivalents of calcium are present.

Den pågældende ester af den benyttede 4-imidazolcarboxylsyre er ikke kritisk for fremgangsmåden ifølge opfindelsen. De lavere alkyl-estere er fordelagtige, fordi alkoholerne, hvoraf de er afledt, ikke er dyre, og udbytterne ved anvendelsen af de lavere alkylestere er gode.The ester in question of the 4-imidazole carboxylic acid used is not critical to the process of the invention. The lower alkyl esters are advantageous because the alcohols from which they are derived are not expensive and the yields of the use of the lower alkyl esters are good.

En protonafgivende forbindelse, som den ved fremgangsmåden ifølge opfindelsen krævede, er en forbindelse, som afgiver en hydrogenion.A proton-releasing compound, as required by the process of the invention, is a compound which gives off a hydrogen ion.

I alt tre ækvivalenter protoner pr. ækvivalent ester skal tilvejebringes til isolering af den frie hydroxyraethylimidazolforbindelse.A total of three equivalents of protons per equivalent ester must be provided to isolate the free hydroxyraethylimidazole compound.

De kan tilføres under reaktionen, under oparbejdningen eller under en kombination af begge. De yderligere protonafgivende forbindelser, der anvendes ved fremgangsmåden ifølge opfindelsen, er fortrinsvis i handelen gående materialer.They can be added during the reaction, during the work-up or during a combination of both. The additional proton-releasing compounds used in the process of the invention are preferably commercially available materials.

4 1437494 143749

En alkohol,;såsom fortrinsvis en lavere alkanol indeholdende 1-6, men helst 2-4, carbonatomer, eller en cykloalkanol, som fortrinsvis indeholder 5-6 carbonatomer, er mest hensigtsmæssig at benytte til opnåelse af to af de nødvendige 3 ækvivalenter protoner. Den kan være til stede i reaktionsblandingen i enhver mængde indtil ca. 2 ækvivalenter alkohol pr. ækvivalent ester. Større mængder kan anvendes, men forårsager hurtigere tab af alkali- eller jordalkalimetallet som følge af dannelse af hydrogengas. Alternativt kan to ækvivalenter eller mere af alkoholen tilsættes under oparbe jdning. I stedet for disse alkoholer kan forbindelser med en pKa-værdi i intervallet 16-35, fortrinsvis 16-18, hvilke forbindelser ikke reduceres under fremgangsmåden, anvendes til tilføring af de første to protoner. For eksempel til-' fører det opløsende ammoniak til at begynde med protoner, når en yderligere protonkilde, såsom en alkohol, ikke tilsættes før oparbejdningsfasen.An alcohol, such as preferably a lower alkanol containing 1-6, but most preferably 2-4, carbon atoms, or a cycloalkanol, preferably containing 5-6 carbon atoms, is most convenient to use to obtain two of the required 3 equivalents of protons. It may be present in the reaction mixture in any amount up to ca. 2 equivalents of alcohol per equivalent ester. Larger amounts can be used, but cause faster loss of the alkali or alkaline earth metal due to hydrogen gas formation. Alternatively, two equivalents or more of the alcohol may be added during working up. Instead of these alcohols, compounds having a pKa value in the range of 16-35, preferably 16-18, which compounds are not reduced during the process can be used to supply the first two protons. For example, dissolving ammonia initially leads to protons when an additional proton source, such as an alcohol, is not added before the reprocessing phase.

Ved oparbejdningen og efter alkoholtilsætningen tilsættes 4 ækvivalenter protoner pr. ækvivalent ester fra en protonafgivende forbindelse, der er mere sur end hydroxymethylimidazol, såsom vand, ammoniumsulfat, eddikesyre eller fortrinsvis ammoniumchlorid. 3 af disse ækvivalenter tjener til neutralisering af de 2 forinden dannede ækvivalenter alkoxid (eller anden base) plus det ene ækvivalent alkoxid, der dannes af imidazolesteren under reduktionen. Det fjerde ækvivalent tilfører det sidste ækvivalent protoner til hydroxymethylimidazolanionen, der er til stede på dette tidspunkt. Hvis man ønsker at isolere imidazol-alkoholen som syreadditionssaltet, må et femte ækvivalent protoner tilføres fra en passende stærk syre, såsom hydrogenchlorid.At work-up and after the alcohol addition, 4 equivalents of protons are added. equivalent ester from a proton-releasing compound which is more acidic than hydroxymethylimidazole such as water, ammonium sulfate, acetic acid or preferably ammonium chloride. 3 of these equivalents serve to neutralize the 2 previously formed equivalents of alkoxide (or other base) plus the one equivalent of alkoxide formed by the imidazole ester during the reduction. The fourth equivalent adds the last equivalent of protons to the hydroxymethylimidazole anion present at this time. If one wishes to isolate the imidazole alcohol as the acid addition salt, a fifth equivalent of protons must be added from a suitably strong acid such as hydrogen chloride.

Metaller, der anvendes ved fremgangsmåden, er f.eks. alkalimetaller, såsom natrium, kalium eller lithium, eller et jordalkalimetal, såsom calcium. Imidlertid foretrækkes natrium eller lithium ud fra et økonomisk standpunkt til drift i stor skala og med henblik på let udførelse af fremgangsmåden.Metals used in the process are e.g. alkali metals such as sodium, potassium or lithium, or an alkaline earth metal such as calcium. However, from an economic standpoint, sodium or lithium is preferred for large-scale operation and for ease of execution of the process.

Reaktionen udføres ved eller under kogepunktet for ammoniakopløsningen eller -blandingen, hensigtsmæssigt ved en temperatur i intervallet fra ca. 25°C til ca. -70°C, fortrinsvis fra ca. -35°C til ca. -50°C. Alternativt kan reaktionen udføres ved en højere temperatur under et tryk, ved hvilket ammoniakken er flydende.The reaction is carried out at or below the boiling point of the ammonia solution or mixture, conveniently at a temperature in the range of from about. 25 ° C to approx. -70 ° C, preferably from ca. -35 ° C to approx. -50 ° C. Alternatively, the reaction may be carried out at a higher temperature under a pressure at which the ammonia is liquid.

5 1437495 143749

Det foretrækkes ved fremgangsmåden ifølge opfindelsen at opløse metallet i flydende ammoniak og til denne opløsning at tilsætte imidazol-carboxylsyreesteren og en alkohol. Fortrinsvis tilsættes esteren og alkoholen samtidig, enten separat eller blandet forinden, eller også, hvilket er mest hensigtsmæssigt, tilsættes alkoholen efterfulgt øjeblikkeligt af esteren. Den sidstnævnte metode er særlig hensigtsmæssig ved drift i stor skala. Når alkoholen tilsættes først efterfulgt af esteren, foretrækkes det at anvende en mindre sur alkohol, såsom t-butanol, n-butanol eller isopropanol i stedet for ethanol eller methanol.It is preferred by the process of the invention to dissolve the metal in liquid ammonia and to add to the solution the imidazole carboxylic acid ester and an alcohol. Preferably, the ester and alcohol are added simultaneously, either separately or mixed beforehand, or also, which is most convenient, the alcohol is followed immediately by the ester. The latter method is particularly suitable for large-scale operation. When the alcohol is first added followed by the ester, it is preferred to use a less acidic alcohol such as t-butanol, n-butanol or isopropanol instead of ethanol or methanol.

Den alkaliske reaktionsblanding oparbejdes fortrinsvis ved køling under reaktionen, f.eks. ved tilsætning af en alkohol, hvorpå den mere sure protonkilde tilsættes, såsom ammoniumchlorid, og ammoniakken derpå afdampes. Filtrering og inddampning resulterer i en rest, som indeholder 4-(hydroxymethyl)imidazolforbindelsen med formlen II.The alkaline reaction mixture is preferably worked up by cooling during the reaction, e.g. by adding an alcohol to which the more acidic proton source is added, such as ammonium chloride, and the ammonia is then evaporated. Filtration and evaporation result in a residue containing the 4- (hydroxymethyl) imidazole compound of formula II.

Alternativt kan man køle under reaktionen ved tilsætning af vand. Derpå ekstraheres 4-(hydroxymethyl)imidazolen med formlen II med en alkohol med 3-6 carbonatomer, såsom n-butanol, n-pentanol eller fortrinsvis t-butanol. Afdampning af alkoholen fra ekstrakterne resulterer i en rest, som indeholder 4-(hydroxymethyl)imidazolen.Alternatively, one can cool during the reaction by adding water. Then the 4- (hydroxymethyl) imidazole of formula II is extracted with an alcohol of 3-6 carbon atoms such as n-butanol, n-pentanol or preferably t-butanol. Evaporation of the alcohol from the extracts results in a residue containing the 4- (hydroxymethyl) imidazole.

4-(hydroxymethyl)imidazolforbindelsen isoleres fortrinsvis som et syreadditionssalt, fortrinsvis hydrochloridsaltet, ved behandling med en syre under oparbejdning, f.eks. ved behandling med hydrogen-chlorid, og krystallisation fra et passende opløsningsmiddel, såsom isopropanol, eller fortrinsvis fra en opløsningsmiddelblanding, såsom isopropanol/acetone/ethylether.The 4- (hydroxymethyl) imidazole compound is preferably isolated as an acid addition salt, preferably the hydrochloride salt, by treatment with an acid during work-up, e.g. by treatment with hydrogen chloride, and crystallization from a suitable solvent such as isopropanol, or preferably from a solvent mixture such as isopropanol / acetone / ethyl ether.

4-(hydroxymethyl)imidazolerne er nyttige som mellemprodukter for fremstilling af farmakologisk aktive forbindelser, især histamin-Hg-antagonister, f.eks. N-methyl-N’-[2-((5-H-4-imidazolyl)methylthio)-ethyl]thiourinstof samt N-cyano-N’-methyl-N"-[2-((5-R-4-imidazolyl) methylthio)ethyl]guanidinforbindelser. Histamin-Hg-antagonister virker som histamin-H2-receptorer, der, som beskrevet af Black et al. (Nature 1972, 236, 385), kan defineres som de histaminreceptorer, der ikke blokeres af "antihistaminer", såsom mepyramin, men blokeres af burima- 6 U3749 mid. Blokeringen af histamin-Hj-receptorer er nyttig til inhibe-ring af de biologiske virkninger af histamin, som ikke inhiberes af "antihistaminer". Histamin-H2~antagonister er nyttige, for eksempel som inhibitorer af mavesyresekretion.The 4- (hydroxymethyl) imidazoles are useful as intermediates for the preparation of pharmacologically active compounds, especially histamine Hg antagonists, e.g. N-methyl-N '- [2 - ((5-H-4-imidazolyl) methylthio) -ethyl] thiourea and N-cyano-N'-methyl-N "- [2 - ((5-R-4- histamine Hg antagonists act as histamine H2 receptors which, as described by Black et al. (Nature 1972, 236, 385), can be defined as those histamine receptors which are not blocked by antihistamines ", such as mepyramine, but are blocked by burimamide. The blocking of histamine H 2 receptors is useful for inhibiting the biological effects of histamine that are not inhibited by" antihistamines ". Histamine H2 antagonists are useful , for example, as inhibitors of gastric acid secretion.

De efterfølgende eksempler illustrerer fremgangsmåden ifølge opfindelsen .The following examples illustrate the process of the invention.

I de efterfølgende eksempler refererer de anførte udbytter til de rå, isolerede produkter. I samtlige tilfælde, medmindre andet er anført, er produkterne mindst 90S rene. Den væsentligste tilstedeværende urenhed hidrørende fra denne procedure er ammoniumchlorid, som sædvanligvis er til stede i en mængde fra ca. 1 til ca. 7 vægts. 5-R-imidazol-4-carboxylsyre er til stede i en mængde på ca.In the following examples, the yields given refer to the raw, isolated products. In all cases, unless otherwise stated, the products are at least 90S clean. The major impurity present from this procedure is ammonium chloride, which is usually present in an amount of from 1 to approx. 7 weight. 5-R-imidazole-4-carboxylic acid is present in an amount of approx.

1% eller mindre, forudsat at de foretrukne procedurer følges, men kan andrage 25-50%, hvis tilsætningsordenen for ester til alkali-metal/calcium-ammoniak vendes om (eksempel 4). I intet tilfælde fandtes produkter hidrørende fra reduktion af imidazolringen. Når man ønsker at opnå et produkt med den højeste renhed, især når store mængder 5-R-imidazol-4-carboxylsyre er til stede, foretrækkes oparbejdningsproceduren anført i eksemplerne 2 og 4. R betegner som nævnt hydrogen eller -alkyl.1% or less, provided the preferred procedures are followed, but may be 25-50% if the addition order of ester for alkali metal / calcium ammonia is reversed (Example 4). In no case were products resulting from reduction of the imidazole ring. When one wishes to obtain a product of the highest purity, especially when large amounts of 5-R-imidazole-4-carboxylic acid are present, the work-up procedure set forth in Examples 2 and 4. is preferably referred to as hydrogen or alkyl.

Eksempel 1Example 1

En 2 liter kolbe blev udstyret med en ovenover anbragt omrører samt et nitrogenindløb samt påfyldt 600 ml vandfri ammoniak. Et tøris-acetonekølebad blev anvendt til at lette opsamlingen af ammoniak samt til køling under reaktionen. Efter at ammoniakken var opsamlet, blev natrium (33 g, 1,435 mol) tilsat i portioner og opløst, hvilket resulterede i en dybblå farve, t-butanol (25 ml, 0,266 mol) blev sat til denne opløsning. 5-methyl-4-imidazolcarboxyl-syreethylester (50 g, 0,32 mol) blev tilsat portionsvis. Efter tilsætning af esteren blev den blå opløsning omrørt i 5 minutter, og methanol (100 ml) blev dråbevis tilsat, hvilket fik den blå farve til at forsvinde, efter at nogle få milliliter var bleyet tilsat. Ammoniumchlorid (78 g, 1,458 mol) blev tilsat i portioner. Ammoniakken blev afdampet, og isopropanol (700 ml) blev sat til resten, og blandingen blev opvarmet under tilbagesvaling i 30 mi- 7 143749 nutter under kraftig omrøring. Blandingen blev kølet til 40°C og syrnet (pH ca. 1) med hydrogenchloridgas. Vand (10 ml) blev tilsat, og blandingen blev omrørt ved 50°C i 30 minutter. Blandingen blev filtreret, og filterkagen blev vasket med 200 ml varm (40-50°C) isopropanol. Opløsningen blev inddampet til 100 ml og fortyndet med acetone (400 ml) samt ether (100 ml). Produktet blev opsamlet og tørret til opnåelse af 46,0 g (96%) 4-(hydroxymethyl) -5-methylimidazolhydrochlorid med smeltepunkt 240°C (de-komponering).A 2 liter flask was equipped with an overhead stirrer as well as a nitrogen inlet and filled with 600 ml of anhydrous ammonia. A dry ice-acetone cooling bath was used to facilitate the collection of ammonia as well as for cooling during the reaction. After the ammonia was collected, sodium (33 g, 1.435 mol) was added in portions and dissolved, resulting in a deep blue color, t-butanol (25 ml, 0.266 mol) was added to this solution. 5-methyl-4-imidazole carboxylic acid ethyl ester (50 g, 0.32 mol) was added portionwise. After addition of the ester, the blue solution was stirred for 5 minutes and methanol (100 ml) was added dropwise, causing the blue color to disappear after a few milliliters of bleach were added. Ammonium chloride (78 g, 1.458 mol) was added in portions. The ammonia was evaporated and isopropanol (700 ml) was added to the residue and the mixture was heated under reflux for 30 minutes under vigorous stirring. The mixture was cooled to 40 ° C and acidified (pH about 1) with hydrogen chloride gas. Water (10 ml) was added and the mixture was stirred at 50 ° C for 30 minutes. The mixture was filtered and the filter cake washed with 200 ml of warm (40-50 ° C) isopropanol. The solution was evaporated to 100 ml and diluted with acetone (400 ml) and ether (100 ml). The product was collected and dried to give 46.0 g (96%) of 4- (hydroxymethyl) -5-methylimidazole hydrochloride, mp 240 ° C (decomposition).

Eksempel 2Example 2

Ved fremgangsmåden ifølge eksempel 1 kan 4-(hydroxymethyl)-5-methyl-imidazolen alternativt isoleres som basen ved hjælp af følgende fremgangsmåde;Alternatively, by the method of Example 1, the 4- (hydroxymethyl) -5-methyl-imidazole can be isolated as the base by the following procedure;

Efter at ammoniakken er fjernet ved hjælp af fordampning under proceduren ifølge eksempel 1 sættes isopropanol (700 ml) til resten, og der opvarmes under tilbagesvaling i 30 minutter under kraftig omrøring, hvorefter den resulterende blanding filtreres, og iso-propanolen fjernes ved inddampning i vakuun til opnåelse af 4-(hydroxymethyl)-5-methylimidazol som resten.After the ammonia is removed by evaporation during the procedure of Example 1, isopropanol (700 ml) is added to the residue and heated under reflux for 30 minutes with vigorous stirring, then the resulting mixture is filtered and the isopropanol removed by evaporation in vacuo to give 4- (hydroxymethyl) -5-methylimidazole as the residue.

Eksempel 3Example 3

En 12-liter kolbe blev udstyret med en ovenover anbragt omrører og et nitrogenindløb og påfyldt 6 liter ammoniak. Et tøris-ace-tone-kølebad blev anvendt til at lette opsamlingen af ammoniak og til at frembringe køling under reaktionen. Efter at ammoniakken var opsamlet, blev natrium (335 g, 15,23 mol) tilsat i portioner og opløst i ammoniakken, hvilket resulterede i en dybblå opløsning. Tilsætningen af natrium krævede ca. 15 minutter. 5-methyl-4-imid-azolcarboxylsyreethylester (500 g, 3,25 mol) blev sat til 400 ml tør ethanol til opnåelse af et vådt pulver. Dette våde pulver blev portionsvis under forsigtighed sat til natrium-ammoniakopløsningen i løbet af et tidsrum på ca. 30 minutter. Efter at tilsætningen var afsluttet, blev 1 liter methanol forsigtigt tilsat. Ammonium-chlorid (810 g, 15,28 mol) blev meget forsigtigt tilsat, indtil den blå farve var forsvundet, hvorefter den resterende mængde ammonium-chlorid kunne tilsættes hurtigere. Efter tilsætningen af ammonium- 8 143749 chloridet blev ammoniakken afdampet under anvendelse af et koldt-vandsvarmebad. Efterhånden som blandingens volumen blev formindsket, blev opvarmningsbadet gjort varmere. Da næsten al ammoniakken var forsvundet, blev blandingen opvarmet med damp under et vakuum til fjernelse af de sidste spor af ammoniak. Fjernelsen af ammoniak kræver 7-15 timer. Isopropanol (6 liter) blev sat til resten, og der blev opvarmet under tilbagesvaling i 1 time under kraftig omrøring. Vand (100 ml) blev derpå tilsat, og omrøringen blev fortsat i 10 minutter. Blandingen blev derpå kølet til ca.A 12-liter flask was fitted with an overhead stirrer and a nitrogen inlet and filled with 6 liters of ammonia. A dry ice-ace tone cooling bath was used to facilitate the collection of ammonia and to produce cooling during the reaction. After the ammonia was collected, sodium (335 g, 15.23 mol) was added in portions and dissolved in the ammonia, resulting in a deep blue solution. The addition of sodium required approx. 15 minutes. 5-methyl-4-imide-azole-carboxylic acid ethyl ester (500 g, 3.25 moles) was added to 400 ml of dry ethanol to give a wet powder. This wet powder was added cautiously to the sodium ammonia solution over a period of approx. 30 minutes. After the addition was complete, 1 liter of methanol was gently added. Ammonium chloride (810 g, 15.28 mol) was added very gently until the blue color disappeared, and the remaining amount of ammonium chloride could be added more quickly. After the addition of the ammonium chloride, the ammonia was evaporated using a cold-water hot bath. As the volume of the mixture decreased, the heating bath became warmer. When almost all the ammonia had disappeared, the mixture was heated with steam under a vacuum to remove the last traces of ammonia. The removal of ammonia requires 7-15 hours. Isopropanol (6 liters) was added to the residue and heated under reflux for 1 hour with vigorous stirring. Water (100 ml) was then added and stirring was continued for 10 minutes. The mixture was then cooled to ca.

40°C og syrnet med hydrogenchloridgas samt filtreret. Filterkagen blev vasket med varm isopropanol, og det kombinerede filtrat blev inddampet til ca. 1 liter og fortyndet med 4 liter acetone samt 2 liter ethylether. Produktet blev opsamlet og tørret ved 60°C under vakuum til opnåelse af 4-(hydroxymethyl)-5-methylimidazol, hydro-chlorid i et udbytte på 97%.40 ° C and acidified with hydrogen chloride gas and filtered. The filter cake was washed with warm isopropanol and the combined filtrate was evaporated to ca. 1 liter and diluted with 4 liters of acetone and 2 liters of ethyl ether. The product was collected and dried at 60 ° C under vacuum to give 4- (hydroxymethyl) -5-methylimidazole hydrochloride in 97% yield.

Eksempel 4Example 4

En suspension af 5-methyl-4-imidazolcarboxylsyreethylester (3,0 g, 0,02 mol) og absolut ethanol (10 ml) blev omrørt ved tøristemperatur i en tør 200 ml kolbe, der var udstyret med en tøristilbagesvaler, da 60-80 ml ammoniak blev tilsat. (Alternativt kan 10 ml t-butanol anvendes i stedet for ethanol).A suspension of 5-methyl-4-imidazole carboxylic acid ethyl ester (3.0 g, 0.02 mole) and absolute ethanol (10 ml) was stirred at drying temperature in a dry 200 ml flask equipped with a drying back cooler when 60-80 ml of ammonia was added. (Alternatively, 10 ml of t-butanol can be used instead of ethanol).

Små stykker natrium (fra xylen) blev tilsat i løbet af 15-20 minutter.. Opløsningen blev klar under tilsætningen, hvorefter en blå 'farve holdt sig i et minut, og opløsningen blev uklar. Dette krævede 2,2-2,7 g natrium. Reaktionen kræver 20-30 minutter.Small pieces of sodium (from xylene) were added over 15-20 minutes. The solution became clear during the addition, after which a blue color remained for one minute and the solution became cloudy. This required 2.2-2.7 g of sodium. The reaction requires 20-30 minutes.

Ammoniakken fik lov til at fordampe, og vand (50 ml) samt fast natriumchlorid blev tilsat. Den vandige opløsning blev ekstraheret med flere 40 ml portioner t-butanol. Natriumchlorid blev tilsat under forløbet af ekstraktionen.The ammonia was allowed to evaporate and water (50 ml) and solid sodium chloride were added. The aqueous solution was extracted with several 40 ml portions of t-butanol. Sodium chloride was added during the course of the extraction.

Alkohollaget blev afdampet. 4-(hydroxymethyl)-5-methylimidazolen, som var til stede i resten, blev omdannet til hydrochloridsaltet ved behandling med ether og isopropanol samt ved at føre hydrogenchloridgas ind i den bratkølede opløsning. 4-(hydroxymethyl)-5-methylimidazol,hydrochloridet (1,6 g, 55%) blev isoleret ved hjælp af filtrering.The alcohol layer was evaporated. The 4- (hydroxymethyl) -5-methylimidazole present in the residue was converted to the hydrochloride salt by treatment with ether and isopropanol as well as by introducing hydrogen chloride gas into the quenched solution. 4- (hydroxymethyl) -5-methylimidazole, the hydrochloride (1.6 g, 55%) was isolated by filtration.

9 1437499 143749

Eksempel 5Example 5

En 1 liter kolbe, som var udstyret med en ovenover anbragt omrører og et nitrogenindløb, blev påfyldt 300 ml vandfri ammoniak. Kalium (26,0 g, 0,66 mol) blev tilsat, t-butanol (12,5 ml, 0,133 mol) blev tilsat, hvorefter 5-methyl-4-imidazolcarboxylsyreethylester (25,0 g, 0,16 mol) blev tilsat portionsvis i løbet af 20 minutter. Reaktionsblandingen blev omrørt i 5 minutter og derefter kølet med 50 ml methanol. Ammoniumchlorid (40,0 g, 0,74 mol) samt ispropanol (400 ml) blev tilsat, og ammoniakken blev fjernet ved hjælp af destillation. Hydrogenchloridgas blev tilsat til ca. pH 1, og de faste stoffer blev frafiltreret. Filtratet blev inddampet til 60 ml, og acetone (300 ml) blev tilsat. Produktet blev opsamlet ved hjælp af filtrering og tørret til opnåelse af 24 g (98%) 4-(hydroxymethyl) -5-methylimidazol,hydrochlorid.A 1 liter flask, equipped with a stirrer and a nitrogen inlet, was charged with 300 ml of anhydrous ammonia. Potassium (26.0 g, 0.66 mole) was added, t-butanol (12.5 mL, 0.133 mole) was added, and 5-methyl-4-imidazole carboxylic acid ethyl ester (25.0 g, 0.16 mole) was added. added portionwise over 20 minutes. The reaction mixture was stirred for 5 minutes and then cooled with 50 ml of methanol. Ammonium chloride (40.0 g, 0.74 mole) and ice-propanol (400 ml) were added and the ammonia was removed by distillation. Hydrogen chloride gas was added to ca. pH 1 and the solids were filtered off. The filtrate was evaporated to 60 ml and acetone (300 ml) was added. The product was collected by filtration and dried to give 24 g (98%) of 4- (hydroxymethyl) -5-methylimidazole hydrochloride.

Eksempel 6Example 6

En 2 liter kolbe, der var forsynet med en ovenover anbragt omrører og et nitrogenindløb, blev påfyldt 700 ml vandfri ammoniak. Calcium (29,0 g, 0,723 mol) blev forsigtigt tilsat i portioner, t-butanol (25 ml, 0,266 mol) blev tilsat i en portion, og 5-methyl-4-imidazol-carboxylsyreethylester (50 g, 0,32 mol) blev portionsvis tilsat i løbet af 30 minutter. Den blå opløsning blev omrørt i 40 minutter, og methanol (120 ml) blev dråbevis tilsat. Ammoniumchlorid (80,0 g, 1,48 mol) samt isopropanol (800 ml) blev tilsat, og ammoniakken blev fjernet. Hydrogenchloridgas blev tilsat (pH ca. 1), og de faste stoffer blev filtreret fra. Filtratet blev inddampet til 100 ml, og acetone (500 ml) blev tilsat. Produktet blev opsamlet og tørret til opnåelse af 4-hydroxymethyl-5-methylimidazol,hydro-chlorid (23,0 g 65% rent materiale, udbytte 30%).A 2 liter flask fitted with an overhead stirrer and a nitrogen inlet was charged with 700 ml of anhydrous ammonia. Calcium (29.0 g, 0.723 mol) was gently added in portions, t-butanol (25 mL, 0.266 mol) was added in one portion, and 5-methyl-4-imidazole carboxylic acid ethyl ester (50 g, 0.32 mol) ) was added portionwise over 30 minutes. The blue solution was stirred for 40 minutes and methanol (120 ml) was added dropwise. Ammonium chloride (80.0 g, 1.48 mol) and isopropanol (800 ml) were added and the ammonia was removed. Hydrogen chloride gas was added (pH about 1) and the solids were filtered off. The filtrate was evaporated to 100 ml and acetone (500 ml) was added. The product was collected and dried to give 4-hydroxymethyl-5-methylimidazole hydrochloride (23.0 g of 65% pure material, yield 30%).

Eksempel 7Example 7

En 2 liter kolbe blev udstyret med et nitrogenindløb og en ovenover placeret omrører. Ved hjælp af køling med et tøris-acetonebad blev ca. 500 ml flydende ammoniak opsamlet i kolben. Lithiummetal (6,3 g, 0,895 mol, ca. 25% overskud) blev opløst i flydende ammoniak til 10 U3749 dannelse af en blå opløsning. Under kontinuerlig køling og omrøring blev 5-methyl-4-imidazolcarboxylsyreethylester (27,58 g, 0,179 mol) tilsat i meget små portioner. Efter at esteren var blevet tilsat, vedblev reaktionsopløsningen at være blå, og den blev omrørt i 5 minutter. Den blå opløsning blev kølet ved dråbevis tilsætning af 60 ml methanol. Derpå tilsattes oxalsyrepulver (41 g, 0,45 mol) forsigtigt. Ammoniak blev afdampet på et varmt vandbad til opnåelse af en tyktflydende væske, som blev optaget i 500 ml isopropanol. Blandingen blev i en halv time opvarmet til 60-75°C og kølet før filtrering. Filtratet blev syrnet til pH 1 med hydrogenchloridgas og atter filtreret. Dette andet filtrat blev inddampet til en tyktflydende væske og fortyndet med acetone. Produktet blev opsamlet og tørret til opnåelse af 20,7 g (78%) 4-(hydroxymethyl)-5-methylimidazol, hydrochlorid.A 2 liter flask was equipped with a nitrogen inlet and a stirrer located above. By cooling with a dry ice-acetone bath, approx. 500 ml of liquid ammonia collected in the flask. Lithium metal (6.3 g, 0.895 mole, about 25% excess) was dissolved in liquid ammonia to form a blue solution. With continuous cooling and stirring, 5-methyl-4-imidazole carboxylic acid ethyl ester (27.58 g, 0.179 mol) was added in very small portions. After the ester was added, the reaction solution remained blue and it was stirred for 5 minutes. The blue solution was cooled by the dropwise addition of 60 ml of methanol. Then oxalic acid powder (41 g, 0.45 mol) was added carefully. Ammonia was evaporated on a hot water bath to give a viscous liquid which was taken up in 500 ml of isopropanol. The mixture was heated to 60-75 ° C for half an hour and cooled before filtration. The filtrate was acidified to pH 1 with hydrogen chloride gas and filtered again. This second filtrate was evaporated to a viscous liquid and diluted with acetone. The product was collected and dried to give 20.7 g (78%) of 4- (hydroxymethyl) -5-methylimidazole hydrochloride.

Eksempel 8Example 8

En 5 liter kolbe blev udstyret med en ovenover anbragt omrører og skyllet med nitrogen. Beholderen blev påfyldt 2,7 liter vandfri, flydende ammoniak uden ydre køling. Efter at ammoniakken var opsamlet, blev natrium (112 g, 4,87 mol) tilsat i små portioner. Efter at natriummet var blevet opløst, blev langsom omrøring igangssat, og 5-methyl-4-imidazolcarboxylsyreethylester (150 g, 0,974 mol, foreliggende som 0,5 g tabletter) tilsat i portioner på 2 g med 25-30 sekunders mellemrum. Temperaturen forblev omkring -28°C under denne tilsætning. Efter tilsætningen af esteren vedblev opløsningen at være blå. Methanol, 300 ml, blev forsigtigt tilsat dråbevis til fjernelse af den blå farve (hvis den blå farve ikke forsvinder efter methanoltilsætnin-gen, bør omrøring fortsættes, indtil farven forsvinder). Efter metha-noltilsætningen blev ammoniumchlorid (265 g, 4,97 mol, ca. 2% overskud i forhold til mol natrium) tilsat portionsvis med forsigtighed.A 5 liter flask was fitted with an overhead stirrer and rinsed with nitrogen. The vessel was charged with 2.7 liters of anhydrous liquid ammonia without external cooling. After the ammonia was collected, sodium (112 g, 4.87 mol) was added in small portions. After the sodium was dissolved, slow stirring was started and 5-methyl-4-imidazole carboxylic acid ethyl ester (150 g, 0.974 mol, available as 0.5 g tablets) was added in 2 g portions at 25-30 second intervals. The temperature remained around -28 ° C during this addition. After the addition of the ester, the solution remained blue. Methanol, 300 ml, was gently added dropwise to remove the blue color (if the blue color does not disappear after the methanol addition, stirring should be continued until the color disappears). After the methanol addition, ammonium chloride (265 g, 4.97 mole, about 2% excess mole sodium) was added cautiously.

Efter tilsætningen af ammoniumchlorid blev ammoniak afdampet til opnåelse af en tyktflydende væske. Temperaturen af beholderens vægge bør ikke overstige 50°C. Isopropanol (2,1 liter) blev tilsat, og blandingen blev kraftigt omrørt under opvarmning af blandingen til 75°C. Blandingen blev derpå syrnet med hydrogenchloridgas (til pH ca.After the addition of ammonium chloride, ammonia was evaporated to give a viscous liquid. The temperature of the container walls should not exceed 50 ° C. Isopropanol (2.1 liters) was added and the mixture was stirred vigorously while heating the mixture to 75 ° C. The mixture was then acidified with hydrogen chloride gas (to pH ca.

1), og 30 ml vand blev tilsat. Blandingen blev omrørt i 15 minutter og kølet til 40-50°C samt filtreret. Resten blev vasket med varm isopro- 143749 11 panol (2 x 300 ml). Filtratet og vaskevæskeme blev inddampet til næsten tørhed (tyktflydende væske), og fortyndet med acetone (1,5 liter). Produktet blev opsamlet og tørret til opnåelse af 125,8 g, 87%)4-(hydroxymethyl )-5-methylimidazol ,iiydrochlorid.1) and 30 ml of water were added. The mixture was stirred for 15 minutes and cooled to 40-50 ° C and filtered. The residue was washed with warm isopropanol (2 x 300 ml). The filtrate and washings were evaporated to near dryness (viscous liquid) and diluted with acetone (1.5 liters). The product was collected and dried to give 125.8 g, 87% of 4- (hydroxymethyl) -5-methylimidazole, hydrochloride.

Eksempel 9Example 9

En 5 liter kolbe blev udstyret med en ovenover placeret omrører og skyllet med nitrogen. Beholderen blev påfyldt 2,3 liter vandfri, flydende ammoniak uden ydre køling. Efter at ammoniakken var opsamlet, blev natrium (97 g, 4,22-mol, 2596 molært overskud) tilsat i portioner.A 5 liter flask was fitted with an overhead stirrer and rinsed with nitrogen. The vessel was charged with 2.3 liters of anhydrous liquid ammonia without external cooling. After the ammonia was collected, sodium (97 g, 4.22 mol, 2596 molar excess) was added in portions.

Efter at natriummet var opløst, blev omrøring igangsat, og 5-methyl- 4-imidazolcarboxylsyreethylester (130 g, 0,844 mol, og foreliggende son o,5 g tabletter) blev tilsat i 2 g portioner med ca. 30 sekunders mellemrum. Efter tilsætningen af esteren blev den blå opløsning omrørt i 5 minutter, n-propanol (260 ml) blev forsigtigt tilsat dråbevis til fjernelse af den blå farve (hvis den blå farve ikke forsvinder under n-propanoltilsætningen, bør omrøringen fortsættes, indtil farven forsvinder). Ammoniumchloridet (232 g, 4,34 moi, et 2% overskud i forhold til mol natrium) blev portionsvis tilsat i løbet af 20-30 minutter med forsigtighed. Den resulterende ammoniakblanding..blev inddampet til en tyktflydende væske. Beholderens vægge bør ikke komme op over 50°C. n-propanol (2,0 liter) blev derpå tilsat, og blandingen blev opvarmet under tilbagesvaling i ca. 10 minutter til uddrivning af det meste af den tilbageværende ammoniak. Blandingen blev syrnet til pH ca. 1 med koncentreret saltsyre og omrørt i 15 minutter, medens den blev kølet til ca. 40°C. Blandingen blev filtreret, og kagen blev vasket med 2 x 300 ml varm (ca. 40°C) n-propanol. Filtratet blev under reduceret tryk inddampet til 300 ml, og blandingen blev henstillet ved ca. 20°C i 12 timer. Produktet blev opsamlet og tørret til opnåelse af 90,0 g (72%) 4-(hydroxymethyl)-5-methylimidazol, hydro-chlorid.After the sodium was dissolved, stirring was started and 5-methyl-4-imidazole carboxylic acid ethyl ester (130 g, 0.844 mole, and the present zone of 5 g tablets) was added in 2 g portions with approx. 30 second intervals. After the addition of the ester, the blue solution was stirred for 5 minutes, n-propanol (260 ml) was gently added dropwise to remove the blue color (if the blue color does not disappear during the n-propanol addition, stirring should be continued until the color disappears). . The ammonium chloride (232g, 4.34mL, a 2% excess mole of sodium) was added portionwise over 20-30 minutes with caution. The resulting ammonia mixture was evaporated to a viscous liquid. The container walls should not rise above 50 ° C. n-propanol (2.0 liters) was then added and the mixture was heated under reflux for approx. 10 minutes to expel most of the remaining ammonia. The mixture was acidified to pH ca. 1 with concentrated hydrochloric acid and stirred for 15 minutes while cooling to ca. 40 ° C. The mixture was filtered and the cake was washed with 2 x 300 ml hot (about 40 ° C) n-propanol. The filtrate was evaporated under reduced pressure to 300 ml and the mixture was left to stand at ca. 20 ° C for 12 hours. The product was collected and dried to give 90.0 g (72%) of 4- (hydroxymethyl) -5-methylimidazole, hydrochloride.

Eksempel 10 600 ml flydende ammoniak blev opsamlet i en 1 liter 3-halset kolbe, der var forsynet med nitrogenindløb og en ovenover placeret omrører.Example 10 600 ml of liquid ammonia was collected in a 1 liter 3-neck flask equipped with nitrogen inlet and an overhead stirrer.

Under nitrogen blev 18 g natriummetal opløst i den flydende ammoniak,Under nitrogen, 18 g of sodium metal was dissolved in the liquid ammonia,

DK331976A 1975-08-20 1976-07-22 PROCEDURE FOR THE PREPARATION OF 4- (HYDROXYMETHYL) IMIDAZOLE COMPOUNDS SOA AND ITS ACID ADDITION SALTS DK143749C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60627075A 1975-08-20 1975-08-20
US60627075 1975-08-20
US69047676 1976-05-27
US05/690,476 US4063023A (en) 1975-08-20 1976-05-27 Process for preparing 4-(hydroxymethyl)imidazole compounds

Publications (3)

Publication Number Publication Date
DK331976A DK331976A (en) 1977-02-21
DK143749B true DK143749B (en) 1981-10-05
DK143749C DK143749C (en) 1982-03-22

Family

ID=27085194

Family Applications (1)

Application Number Title Priority Date Filing Date
DK331976A DK143749C (en) 1975-08-20 1976-07-22 PROCEDURE FOR THE PREPARATION OF 4- (HYDROXYMETHYL) IMIDAZOLE COMPOUNDS SOA AND ITS ACID ADDITION SALTS

Country Status (28)

Country Link
JP (1) JPS6025428B2 (en)
AT (1) AT358574B (en)
AU (1) AU496917B2 (en)
CA (1) CA1064940A (en)
DD (1) DD126871A5 (en)
DE (1) DE2637670A1 (en)
DK (1) DK143749C (en)
EG (1) EG12426A (en)
ES (1) ES450371A1 (en)
FI (1) FI64356C (en)
FR (1) FR2321490A1 (en)
GB (1) GB1562811A (en)
GR (1) GR61130B (en)
HU (1) HU177508B (en)
IE (1) IE44020B1 (en)
IL (1) IL50147A (en)
IN (1) IN147803B (en)
LU (1) LU75612A1 (en)
MX (1) MX3532E (en)
NL (1) NL183581C (en)
NO (1) NO145072C (en)
NZ (1) NZ181647A (en)
OA (1) OA05422A (en)
PH (1) PH13166A (en)
PT (1) PT65369B (en)
RO (1) RO72826A (en)
SE (1) SE415097B (en)
YU (1) YU39616B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ184893A (en) * 1976-09-21 1980-11-28 Smith Kline French Lab Pure crystalline form of cimetidine a(n-methyl-n-cyano-n-(-2-(5-methyl-4imidazolyl) methylthio) ethyl)-guanidine andpharmaceutical compositions containing it
DE2800148A1 (en) 1978-01-03 1979-07-12 Basf Ag PROCESS FOR THE PRODUCTION OF 4-METHYL-5-CHLOROMETHYL-IMIDAZOLE
DE2825547A1 (en) * 1978-06-10 1979-12-20 Basf Ag 1-HYDROXYMETHYLIMIDAZOLE AND ITS USE AS CHEMICAL INTERMEDIATES
JPS5914460B2 (en) * 1978-12-27 1984-04-04 相互薬工株式会社 Production method of cimetidine, an anti-H↓2 receptor
JPS63117318U (en) * 1987-01-24 1988-07-29
JPH0619559U (en) * 1992-03-16 1994-03-15 加藤 利夫 toothbrush

Also Published As

Publication number Publication date
FI762306A (en) 1977-02-21
NL7609296A (en) 1977-02-22
YU191376A (en) 1982-08-31
DE2637670A1 (en) 1977-03-03
PH13166A (en) 1980-01-08
OA05422A (en) 1981-03-31
ATA606376A (en) 1980-02-15
AT358574B (en) 1980-09-25
HU177508B (en) 1981-10-28
RO72826A (en) 1982-09-09
FI64356C (en) 1983-11-10
GB1562811A (en) 1980-03-19
DE2637670C2 (en) 1987-02-26
SE415097B (en) 1980-09-08
IE44020L (en) 1977-02-20
PT65369B (en) 1978-01-10
IL50147A (en) 1980-11-30
YU39616B (en) 1985-03-20
NL183581C (en) 1988-12-01
NO145072B (en) 1981-09-28
GR61130B (en) 1978-09-15
EG12426A (en) 1979-03-31
PT65369A (en) 1976-08-01
DK331976A (en) 1977-02-21
AU496917B2 (en) 1978-11-09
NZ181647A (en) 1978-06-02
IN147803B (en) 1980-07-05
LU75612A1 (en) 1977-03-29
FI64356B (en) 1983-07-29
FR2321490B1 (en) 1978-05-05
NO145072C (en) 1982-01-06
NO762866L (en) 1977-02-22
JPS5225770A (en) 1977-02-25
IL50147A0 (en) 1976-09-30
SE7608831L (en) 1977-02-21
MX3532E (en) 1981-02-03
FR2321490A1 (en) 1977-03-18
AU1703976A (en) 1978-02-23
ES450371A1 (en) 1977-12-01
CA1064940A (en) 1979-10-23
DD126871A5 (en) 1977-08-17
NL183581B (en) 1988-07-01
JPS6025428B2 (en) 1985-06-18
IE44020B1 (en) 1981-07-29
DK143749C (en) 1982-03-22

Similar Documents

Publication Publication Date Title
NO762661L (en)
DK143749B (en) PROCEDURE FOR THE PREPARATION OF 4- (HYDROXYMETHYL) IMIDAZOLE COMPOUNDS SOA AND ITS ACID ADDITION SALTS
Leete et al. THE PAPILIONACEOUS ALKALOIDS: XVII. THE SYNTHESIS OF STRUCTURAL ISOMERS OF SPARTEINE
US2425721A (en) Thiophene compounds and methods of obtaining the same
SU683623A3 (en) Method of the preparation of purine derivatives or their salts
KR100656636B1 (en) Process for the preparation of 6-methyl-2-4-methyl-phenyl-imidazo[1,2-a]pyridine-3-n,n-dimethyl-acetamide and intermediates
US4063023A (en) Process for preparing 4-(hydroxymethyl)imidazole compounds
US4412075A (en) Process for the preparation of quinolin-4-ones
US3705895A (en) Process for the direct synthesis of styrylpyridinium chlorides
US4275216A (en) Process for preparing 4(5)-hydroxymethyl 5(4)-lower alkyl imidazoles
SU791232A3 (en) Method of preparing 2-arylamino-2-imidazoline derivatives
US3689502A (en) Preparation of n-(2-alkylthioethyl) nitroimidazoles
US2946791A (en) 2-diarylalkyl-3, 4, 5, 6-tetrahydro-pyrimidines and processes
US2693465A (en) Process of manufacture of g
JP2000219688A (en) Production of heterocyclic compound
US3450709A (en) Process for the preparation of ring-substituted 2-aminoimidazoles
US3324136A (en) Process for 1, 4-ethano-isoquinolin-3-ones
CS198157B2 (en) Process for preparing 2-hydroxymethyl-3-hydoxy-6-/1-hydroxy-2-terc.butylaminoethyl/pyridine and additive salt with acid thereof
SU1480767A3 (en) Method of producing derivatives of dihydroaryloxyalkylamino-1,2,4-triazole or their pharmaceutically acceptable acid-addition salts
US3803141A (en) 10-(1-substituted-3-pyrrolidylmethyl)phenothiazines
NO794289L (en) PROCEDURE FOR PREPARATION OF 7-CHLORO-2-METHYL-3,3A-DIHYDRO-2H, 9H-ISOXAZOLO- (3,2-B) - (1,3) -BENZOXAZIN-9-ON
MXPA02007060A (en) Method for producing heterocyclic compounds.
SU446964A1 (en) The method of obtaining the basic alkyl esters of thiol-carbamic acid
KR790001309B1 (en) Process for prepaing uracil derivatives
SU460631A3 (en) Method for producing phosphorus acid esters

Legal Events

Date Code Title Description
PBP Patent lapsed